Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - Deferred ChargesAmortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Innoviva (INVA) Operating Expenses (2016 - 2026)

Innoviva filings provide 16 years of Operating Expenses readings, the most recent being $41.0 million for Q3 2025.

  • On a quarterly basis, Operating Expenses rose 37.59% to $41.0 million in Q3 2025 year-over-year; TTM through Dec 2025 was $107.2 million, a 13.66% increase, with the full-year FY2025 number at $143.9 million, up 11.27% from a year prior.
  • Operating Expenses hit $41.0 million in Q3 2025 for Innoviva, up from $34.4 million in the prior quarter.
  • In the past five years, Operating Expenses ranged from a high of $87.7 million in Q2 2022 to a low of -$219.2 million in Q3 2022.
  • Median Operating Expenses over the past 5 years was $31.9 million (2025), compared with a mean of $12.8 million.
  • The widest YoY moves for Operating Expenses: up 1956.38% in 2022, down 765.76% in 2022.
  • Innoviva's Operating Expenses stood at -$25.3 million in 2021, then plummeted by 765.76% to -$219.2 million in 2022, then surged by 91.47% to -$18.7 million in 2023, then soared by 259.26% to $29.8 million in 2024, then soared by 37.59% to $41.0 million in 2025.
  • The last three reported values for Operating Expenses were $41.0 million (Q3 2025), $34.4 million (Q2 2025), and $31.9 million (Q1 2025) per Business Quant data.